Orthopediatrics Reports Q3 Gross Margin of 74%

OrthoPediatrics reported third-quarter 2026 revenue of $72.7 million, up 19% year over year, and a net loss of $5.9 million, compared with a $11.8 million loss a year earlier. Gross margin was 74%, and adjusted diluted loss per share was $0.23. The company raised its 2026 revenue guidance to $270 m…